Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
How Pharma Stocks Reacted To Trump's 200% Tariff Threat On Generic Drugs
The shares of Indian pharmaceutical companies plummeted in early trade on Wednesday, July 22, after the US President Donald Trump, announced a phased tariff imposition plan linked to generic drugs. The Nifty Pharma fell nearly 2% in trade on…
Swiss pharma firm Sandoz takes note of proposed US tariffs on generic drugs
“At this stage, it is too early to assess the potential implications, as further details on the implementation and scope of this measure are still required”, particularly regarding the group's geographical presence and its…
Trump's tariff threat on generic drugs: Why this matters for Indian pharma companies
4 min read New Delhi Make us preferred source on Google US President Donald Trump on Tuesday (July 21) said that tariffs on generic drugs in the US will be raised 100% after two years and to 200% thereafter to “reshore” generic pharma…
Pharma stocks decline; Aurobindo Pharma down over 4%
Pharma stocks declined on Wednesday, with Aurobindo Pharma tumbling over 4 per cent, after US President Donald Trump announced steep tariffs on imported generic medicines from August 2028, asserting that the move was aimed at onshoring the…
Indian pharma sees little immediate threat in Trump's 200% tariff plan
While the Indian generic pharmaceutical industry so far remained unscathed during several rounds of US tariff announcements, US President Donal Trump on Wednesday in a Truth Social post said tariffs on economical generics from India will be raised…
Markets in pressure at midday; banking, IT, pharma drag; auto bucks trend
Markets remained under significant pressure through Wednesday's midday session, with the Sensex and Nifty sliding sharply as selling intensified across banking, information technology, and pharmaceutical stocks. As of 12.50 pm, the Sensex was…
Stock Market Today: Why Are Sensex And Nifty Falling? Pharma Tariffs, Rising Oil Weigh | Dynamite News
Post Published By: Ayushi Bisht Updated: 22 July 2026, 10:20 AM IST Mumbai: Indian benchmark indices extended their losses during early trade on Wednesday, with selling pressure spreading across pharmaceutical, banking, information technology and…
Nifty opens lower; pharma stocks bleed, auto sector shines
Benchmarks opened in the red on Wednesday morning, weighed down by rising crude oil prices and geopolitical tensions, even as selective buying in automobile stocks provided some support. The Sensex, which closed at 77,470.11 on Tuesday, opened at…
Trump's proposed 200% tariff is a wake-up call, India's bigger pharma risk lies in China, say experts
India reportedly supplies 47% of all generic prescriptions dispensed in the United States, making India the country's largest source of affordable generic medicines. With US President Donald Trump proposing tariffs of up to 200% on generic drug…
Pharma heavyweights Novo Nordisk and Eli Lilly clash over anti-obesity drug ads
COPENHAGEN: Danish pharmaceuticals heavyweight Novo Nordisk said Tuesday (Jul 21) it is suing arch US rival Eli Lilly over 'false and materially misleading' adverts for its competing weight-loss and anti-diabetes treatments. The Danish maker of…
US tariff threat drags Nifty Pharma 1.4% lower; Lupin, Auropharma lead decline
Pharma stocks fell sharply on Wednesday after the US proposed steep tariffs on generic drug imports, with the Nifty Pharma Index dropping 374 points, or 1.43 per cent, to 25,718 by afternoon trade. Only two of the index's 20 constituents ended in…
Stock Market Today Live, July 22: Pharma stocks will be in focus today after Trump's tariff announcement
Sensex Today, Nifty 50 | Stock Market Live Updates - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 22nd July 2026. The US President, Donald Trump, announced that drugs imported into the…
Why these 8 stocks including Pharma majors will remain in focus on today following Trump's tariff announcement
The US President, Donald Trump, announced that drugs imported into the United States will not be charged any tariff for two years. Following this,100% tariff will be levied for one year period and 200% later. In a post on Truth Social, Trump said…
NewAmsterdam Pharma (NASDAQ:NAMS) Upgraded by BMO Capital Markets to 'Strong-Buy' Rating
NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) was upgraded by BMO Capital Markets to a 'strong-buy' rating in a report released on Monday, Zacks.com reports. Get NewAmsterdam Pharma alerts: A number of other research firms also recently…
Royalty Pharma PLC $RPRX Shares Bought by Swiss National Bank
Swiss National Bank raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 5.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor…
Receive a Daily briefing on Pharma Industry News
Get Started